| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2025 | Feb 27, 2025 | Septerna, Inc. | CFO | Buy | 95.0 | +10,000 | 33.33% | ✗ | $56.9K |
| Feb 19, 2025 | Feb 21, 2025 | Septerna, Inc. | CFO | Buy | 95.0 | +30,000 | 100.00% | ✗ | $172.3K |
| May 15, 2022 | May 17, 2022 | NEKTAR THERAPEUTICS | CFO | Sell | 87.5 | +11,302 | 3.75% | ✗ | $68.9K |
| May 4, 2022 | May 9, 2022 | Rezolute, Inc. | Director | Buy | 95.0 | +52,631 | 5593.09% | ✗ | $200K |
| May 4, 2022 | May 6, 2022 | Rezolute, Inc. | Director | Buy | 95.0 | +52,631 | 111.88% | ✗ | $200K |
| Feb 16, 2022 | Feb 18, 2022 | NEKTAR THERAPEUTICS | CFO | Sell | 42.5 | -7,579 | -2.45% | ✗ | $83K |
| Nov 16, 2021 | Nov 18, 2021 | NEKTAR THERAPEUTICS | CFO | Sell | 26.3 | -24,149 | -8.60% | ✓ | $316.4K |
| Aug 16, 2021 | Aug 18, 2021 | NEKTAR THERAPEUTICS | CFO | Sell | 37.5 | -10,867 | -4.33% | ✓ | $149.5K |
| May 17, 2021 | May 19, 2021 | NEKTAR THERAPEUTICS | CFO | Sell | 42.5 | -7,898 | -3.05% | ✗ | $144.5K |
| Feb 16, 2021 | Feb 18, 2021 | NEKTAR THERAPEUTICS | CFO | Sell | 42.5 | -7,977 | -2.99% | ✗ | $178.4K |
| Feb 2, 2021 | Feb 4, 2021 | NEKTAR THERAPEUTICS | CFO | Sell | 20.0 | -150,000 | -10.03% | ✓ | $3M |
| Nov 16, 2020 | Nov 18, 2020 | NEKTAR THERAPEUTICS | CFO | Sell | 42.5 | -8,276 | -3.52% | ✗ | $140.1K |
| Sep 17, 2020 | Sep 21, 2020 | NEKTAR THERAPEUTICS | CFO | Sell | 51.3 | -2,000 | -0.84% | ✓ | $39.9K |
| Aug 17, 2020 | Aug 19, 2020 | NEKTAR THERAPEUTICS | CFO | Sell | 37.5 | -8,245 | -3.36% | ✓ | $162.2K |
| May 18, 2020 | May 20, 2020 | NEKTAR THERAPEUTICS | CFO | Sell | 37.5 | -7,727 | -3.05% | ✓ | $174.2K |
| Feb 18, 2020 | Feb 20, 2020 | NEKTAR THERAPEUTICS | CFO | Sell | 42.5 | -5,938 | -2.29% | ✗ | $132.7K |
| Nov 18, 2019 | Nov 20, 2019 | NEKTAR THERAPEUTICS | CFO | Sell | 42.5 | -8,863 | -3.89% | ✗ | $159.3K |
| Nov 13, 2019 | Nov 15, 2019 | NEKTAR THERAPEUTICS | CFO | Sell | 26.3 | -25,000 | -9.89% | ✓ | $494.8K |
| Oct 15, 2019 | Oct 17, 2019 | NEKTAR THERAPEUTICS | CFO | Sell | 26.3 | -25,000 | -9.89% | ✓ | $395.8K |
| Sep 16, 2019 | Sep 18, 2019 | NEKTAR THERAPEUTICS | CFO | Sell | 22.5 | -25,000 | -14.06% | ✓ | $513K |
| Aug 16, 2019 | Aug 19, 2019 | NEKTAR THERAPEUTICS | CFO | Sell | 42.5 | -5,063 | -3.96% | ✗ | $91.9K |
| Aug 14, 2019 | Aug 16, 2019 | NEKTAR THERAPEUTICS | CFO | Sell | 17.5 | -25,000 | -16.35% | ✓ | $444.8K |
| Jul 10, 2019 | Jul 12, 2019 | NEKTAR THERAPEUTICS | CFO | Sell | 17.5 | -25,000 | -16.35% | ✓ | $864.3K |
| Jun 17, 2019 | Jun 19, 2019 | NEKTAR THERAPEUTICS | CFO | Sell | 17.5 | -25,000 | -16.35% | ✓ | $842.8K |
| May 16, 2019 | May 17, 2019 | NEKTAR THERAPEUTICS | CFO | Sell | 42.5 | -3,767 | -2.86% | ✗ | $118.2K |
| Feb 19, 2019 | Feb 21, 2019 | NEKTAR THERAPEUTICS | CFO | Sell | 42.5 | -3,592 | -2.65% | ✗ | $152.3K |
| Nov 16, 2018 | Nov 19, 2018 | NEKTAR THERAPEUTICS | CFO | Sell | 42.5 | -6,515 | -5.76% | ✗ | $249.2K |
| Aug 15, 2018 | Aug 16, 2018 | NEKTAR THERAPEUTICS | CFO | Sell | 97.5 | +17,793 | 18.68% | ✗ | $479.3K |
| May 16, 2018 | May 18, 2018 | NEKTAR THERAPEUTICS | CFO | Sell | 40.0 | -4,941 | -4.95% | ✗ | $412K |
| May 1, 2018 | May 3, 2018 | NEKTAR THERAPEUTICS | CFO | Sell | 8.8 | -90,000 | -23.12% | ✓ | $7.6M |
| Feb 16, 2018 | Feb 20, 2018 | NEKTAR THERAPEUTICS | CFO | Sell | 40.0 | -3,477 | -3.37% | ✗ | $288.4K |
| Nov 15, 2017 | Nov 17, 2017 | NEKTAR THERAPEUTICS | CFO | Sell | 97.5 | +13,302 | 20.98% | ✗ | $296.3K |
| Oct 2, 2017 | Oct 3, 2017 | NEKTAR THERAPEUTICS | CFO | Sell | 5.0 | -120,000 | -65.43% | ✓ | $2.9M |
| Aug 16, 2017 | Aug 18, 2017 | NEKTAR THERAPEUTICS | CFO | Sell | 42.5 | -3,177 | -4.77% | ✗ | $61.4K |
| May 16, 2017 | May 18, 2017 | NEKTAR THERAPEUTICS | CFO | Sell | 42.5 | -3,179 | -4.59% | ✗ | $62.1K |
| Mar 2, 2017 | Mar 3, 2017 | NEKTAR THERAPEUTICS | CFO | Sell | 5.0 | -200,000 | -49.04% | ✓ | $3M |
| Feb 16, 2017 | Feb 17, 2017 | NEKTAR THERAPEUTICS | CFO | Sell | 26.3 | -2,359 | -3.29% | ✗ | $31K |
| Nov 16, 2016 | Nov 18, 2016 | NEKTAR THERAPEUTICS | CFO | Sell | 26.3 | -1,654 | -3.13% | ✗ | $23.1K |
| Aug 16, 2016 | Aug 17, 2016 | NEKTAR THERAPEUTICS | CFO | Sell | 22.5 | -3,305 | -5.89% | ✗ | $58K |
| May 16, 2016 | May 18, 2016 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 26.3 | -836 | -9.55% | ✗ | $11.4K |
| Feb 16, 2016 | Feb 18, 2016 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 27.5 | -827 | -11.15% | ✗ | $9.9K |
| Feb 10, 2016 | Feb 12, 2016 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 10.0 | -11,666 | -68.96% | ✓ | $134K |
| Jan 19, 2016 | Jan 21, 2016 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 10.0 | -11,667 | -68.96% | ✓ | $164.7K |
| Dec 3, 2015 | Dec 7, 2015 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 7.5 | -45,001 | -89.55% | ✓ | $714.2K |
| Nov 11, 2015 | Nov 13, 2015 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 7.5 | -45,000 | -90.45% | ✓ | $608.4K |
| Oct 6, 2015 | Oct 8, 2015 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 7.5 | -45,000 | -90.45% | ✓ | $494.6K |
| Sep 23, 2015 | Sep 25, 2015 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 7.5 | -44,999 | -90.45% | ✓ | $586.8K |
| Aug 13, 2015 | Aug 17, 2015 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 7.5 | -33,333 | -87.52% | ✓ | $363K |
| Jul 14, 2015 | Jul 16, 2015 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 7.5 | -33,334 | -88.69% | ✓ | $392.7K |
| Nov 28, 2014 | Dec 2, 2014 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 5.0 | -120,000 | -93.38% | ✓ | $2M |
| Nov 24, 2014 | Nov 26, 2014 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 10.0 | -10,500 | -73.68% | ✓ | $157.9K |
| Nov 3, 2014 | Nov 4, 2014 | NEKTAR THERAPEUTICS | SVP & General Counsel | Sell | 10.0 | -9,900 | -72.52% | ✓ | $136.4K |